Live news related to ARGENX SE stock (NL0010832176): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
DZ Bank AG Research ajuste sa position sur argenx SE ce mardi 13 janvier 2026.
Immunology company argenx announces that the U.S. Food and Drug Administration has agreed to prioritize the review of a supplemental indication for it…
Dutch biotechnology group argenx has announced preliminary net sales of $4.15 billion for fiscal year 2025, a 90% increase year-over-year. The company…
Immunology company argenx has announced a leadership transition, appointing current COO Karen Massey as the new CEO, according to a statement released…
Argenx SE's stock fell by 6.69% midday on December 15, following the halt of the Phase 3 UplighTED study for the subcutaneous efgartigimod in thyroid …
